Well, since I've gone from seven minutes to four minutes, I'm going to restrict myself to two questions.
First to Genome. First of all, I want to thank Mr. Patterson for stepping into the breach. It's an important position you've taken on, and Genome Canada is an important organization. And I appreciate, on behalf of the people of Canada, your willingness to step in as interim CEO.
My first question to you, Mr. Patterson, is with respect to long-term planning. We heard yesterday that Genome's money comes actually from last year's budget rather than this year's budget. So I was wondering how those kinds of financial manipulations actually affect your budgetary planning, particularly your budgetary planning with respect to longer-term planning so that you have some certainty. Because I know these projects take quite a while to reach fruition.